Logo image of BKV

BKV CORPORATION (BKV) Stock Fundamental Analysis

NYSE:BKV - New York Stock Exchange, Inc. - US05603J1088 - Common Stock - Currency: USD

18.6  +0.39 (+2.14%)

After market: 18.6 0 (0%)

Fundamental Rating

2

Taking everything into account, BKV scores 2 out of 10 in our fundamental rating. BKV was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. BKV has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BKV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BKV had negative earnings in the past year.
In the past year BKV had a positive cash flow from operations.
BKV Yearly Net Income VS EBIT VS OCF VS FCFBKV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

The Return On Assets of BKV (-6.40%) is worse than 80.28% of its industry peers.
With a Return On Equity value of -9.16%, BKV is not doing good in the industry: 74.18% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.4%
ROE -9.16%
ROIC N/A
ROA(3y)4.38%
ROA(5y)N/A
ROE(3y)11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKV Yearly ROA, ROE, ROICBKV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

BKV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BKV Yearly Profit, Operating, Gross MarginsBKV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

BKV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BKV has been increased compared to 1 year ago.
The debt/assets ratio for BKV has been reduced compared to a year ago.
BKV Yearly Shares OutstandingBKV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
BKV Yearly Total Debt VS Total AssetsBKV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

BKV has an Altman-Z score of 1.45. This is a bad value and indicates that BKV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.45, BKV perfoms like the industry average, outperforming 53.52% of the companies in the same industry.
The Debt to FCF ratio of BKV is 9.36, which is on the high side as it means it would take BKV, 9.36 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BKV (9.36) is comparable to the rest of the industry.
BKV has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
BKV has a better Debt to Equity ratio (0.11) than 76.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 9.36
Altman-Z 1.45
ROIC/WACCN/A
WACC11.72%
BKV Yearly LT Debt VS Equity VS FCFBKV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BKV has a Current Ratio of 0.57. This is a bad value and indicates that BKV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BKV (0.57) is worse than 81.22% of its industry peers.
BKV has a Quick Ratio of 0.57. This is a bad value and indicates that BKV is not financially healthy enough and could expect problems in meeting its short term obligations.
BKV's Quick ratio of 0.53 is on the low side compared to the rest of the industry. BKV is outperformed by 79.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.53
BKV Yearly Current Assets VS Current LiabilitesBKV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

BKV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -244.20%.
BKV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.68%.
BKV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.09% yearly.
EPS 1Y (TTM)-244.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y4.09%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 54.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, BKV will show a quite strong growth in Revenue. The Revenue will grow by 18.30% on average per year.
EPS Next Y169.38%
EPS Next 2Y79.67%
EPS Next 3Y54.08%
EPS Next 5YN/A
Revenue Next Year27.37%
Revenue Next 2Y21.69%
Revenue Next 3Y18.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BKV Yearly Revenue VS EstimatesBKV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
BKV Yearly EPS VS EstimatesBKV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 1 -1 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

BKV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 18.84, the valuation of BKV can be described as rather expensive.
BKV's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of BKV to the average of the S&P500 Index (20.86), we can say BKV is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 18.84
BKV Price Earnings VS Forward Price EarningsBKV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BKV is valued a bit more expensive than 73.71% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as BKV.
Industry RankSector Rank
P/FCF 89.41
EV/EBITDA 32.88
BKV Per share dataBKV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BKV's earnings are expected to grow with 54.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.67%
EPS Next 3Y54.08%

More info and screens

0

5. Dividend

5.1 Amount

BKV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BKV CORPORATION

NYSE:BKV (5/2/2025, 8:04:01 PM)

After market: 18.6 0 (0%)

18.6

+0.39 (+2.14%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-09 2025-05-09/bmo
Inst Owners20.11%
Inst Owner Change-0.94%
Ins Owners4.84%
Ins Owner Change2.61%
Market Cap1.58B
Analysts84.62
Price Target28.67 (54.14%)
Short Float %6.19%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)46.79%
Min EPS beat(2)-13.01%
Max EPS beat(2)106.59%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.36%
Min Revenue beat(2)-35.28%
Max Revenue beat(2)-3.43%
Revenue beat(4)0
Avg Revenue beat(4)-16.86%
Min Revenue beat(4)-35.28%
Max Revenue beat(4)-3.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.78%
PT rev (3m)0%
EPS NQ rev (1m)85.97%
EPS NQ rev (3m)14.29%
EPS NY rev (1m)-10.77%
EPS NY rev (3m)-7.48%
Revenue NQ rev (1m)7.08%
Revenue NQ rev (3m)12.45%
Revenue NY rev (1m)4.14%
Revenue NY rev (3m)3.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.84
P/S 2.76
P/FCF 89.41
P/OCF 13.29
P/B 1.01
P/tB 1.02
EV/EBITDA 32.88
EPS(TTM)-1.67
EYN/A
EPS(NY)0.99
Fwd EY5.31%
FCF(TTM)0.21
FCFY1.12%
OCF(TTM)1.4
OCFY7.52%
SpS6.73
BVpS18.41
TBVpS18.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.4%
ROE -9.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 3.09%
ROA(3y)4.38%
ROA(5y)N/A
ROE(3y)11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 9.36
Debt/EBITDA 3.14
Cap/Depr 46.31%
Cap/Sales 17.69%
Interest Coverage N/A
Cash Conversion 225.84%
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.53
Altman-Z 1.45
F-Score3
WACC11.72%
ROIC/WACCN/A
Cap/Depr(3y)107.23%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-244.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y169.38%
EPS Next 2Y79.67%
EPS Next 3Y54.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y4.09%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year27.37%
Revenue Next 2Y21.69%
Revenue Next 3Y18.3%
Revenue Next 5YN/A
EBIT growth 1Y-206.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year522.81%
EBIT Next 3Y97.46%
EBIT Next 5YN/A
FCF growth 1Y125.8%
FCF growth 3Y-60.43%
FCF growth 5YN/A
OCF growth 1Y-3.69%
OCF growth 3Y-30.83%
OCF growth 5YN/A